GlassScriptPhysician profile
Scott W Gordon
NPI 1164745824
$8,127.33
in general payments reported to CMS, 2019-2025
25 companies · $2,378 in 2025
The $2,378 reported for 2025 was more than what 86% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,407 · 2020: $1,437 · 2021: $1,782 · 2022: $342 · 2023: $178 · 2024: $602 · 2025: $2,378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,677 · Food and Beverage: $1,481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,676.52 |
| Food and Beverage | $1,481.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,641.05 | 2021-2025 | Prostep, Prophecy, Infinity |
| Arthrex, INC. | $1,496.00 | 2021 | |
| Titan Surgical Group, LLC | $1,407.33 | 2020-2025 | |
| Integra Lifesciences Corporation | $1,242.82 | 2019-2020 | |
| Treace Medical Concepts, INC. | $1,182.54 | 2025 | |
| Smith+Nephew, INC. | $330.28 | 2019-2025 | Grafix Pl, Memofix Super Elastic Nitinol Staple System, Evos Mini |
| Organogenesis INC. | $178.87 | 2021-2025 | Affinity |
| Wright Medical Technology, INC. | $120.29 | 2019 | |
| Linvatec Corporation | $79.26 | 2022-2023 | Linvatec Extremities |
| Biowound Solutions, INC. | $60.71 | 2025 | Bio-Connekt |
| Innovation Technologies INC | $59.88 | 2021 | |
| Restor3d, INC. | $49.33 | 2024 | |
| Depuy Synthes Sales INC. | $47.60 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $43.08 | 2021-2022 | |
| Biocomposites INC | $27.21 | 2025 | Stimulan |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osiris Therapeutics INC. | $19.52 | 2019 | |
| Avanos Medical | $19.37 | 2023 | On-Q* Pump and Accessories |
| Convatec INC. | $18.54 | 2024 | |
| Allergan, INC. | $16.56 | 2019 | |
| Mimedx Group, INC. | $16.11 | 2024 | |
| Heron Therapeutics, INC. | $14.42 | 2025 | Zynrelef |
| Kowa Pharmaceuticals America, INC. | $14.40 | 2022 | |
| Paratek Pharmaceuticals, INC. | $14.24 | 2022 | |
| Bioventus LLC | $14.19 | 2022 | |
| Melinta Therapeutics, LLC | $13.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.